Any current/future new fundraising through debt or equity?

Godrej Consumer Products Limited plans to evaluate short-term financing initially for the acquisition. As of March-end, the company is net cash. They expect to be net debt for about the next six months, assuming current conditions. With expected cash flows in FY'24, the company plans to return to a net cash position by mid-FY'24. No mention of new equity fundraising was made in the provided transcript. The focus appears to be on managing funding through short-term debt initially, then using operating cash flows to deleverage.

Future growth expectations in sales/revenue/volumes?

FY'24 revenue expected to be flat compared to FY'23 due to SKU rationalization, marketing investments, and market development. Margins in FY'24 expected to improve somewhat but not significantly. From FY'25 onwards, confident of low double digits to mid-teens growth in the acquired portfolio. EBITDA margins projected to rise to mid-20s percent from FY'25 onwards, driven by scale and cost synergies. Long-term growth potential for Deodorants category is mid-teens percentage, though a 10% growth rate still makes business case viable. Sexual Wellness category is also viewed as having a strong grow

Future growth expectations in earnings/operating earnings/profits/EPS?

FY'24: Revenue expected to be flat compared to FY'23; margins to improve slightly but not significantly. The acquisition is expected to be EPS dilutive in FY'24. FY'25 and onwards: Confident of achieving low double-digit to mid-teens revenue growth for the acquired business. EBITDA margins expected to rise to mid-20% range from FY'25 onwards, driven by cost synergies and scale. Long-term growth potential is mid-teens in revenue growth, reflecting category potential and company initiatives. Despite 10% growth being a baseline business case, the management ambition is to exceed that with

Godrej ConsumerQ4 FY23Personal Products

Godrej Consumer Q4 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹850.65P/E: 41.1Market Cap: ₹87.3K CrSector: Personal Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

FY'24 revenue expected to be flat compared to FY'23 due to SKU rationalization, marketing investments, and market development.
Margins in FY'24 expected to improve somewhat but not significantly.
From FY'25 onwards, confident of low double digits to mid-teens growth in the acquired portfolio.
EBITDA margins projected to rise to mid-20s percent from FY'25 onwards, driven by scale and cost synergies.
Long-term growth potential for Deodorants category is mid-teens percentage, though a 10% growth rate still makes business case viable.
Sexual Wellness category is also viewed as having a strong growth runway.
Focus on simplifying SKUs and rationalizing non-core products to support growth.
Expected to leverage GCPL's larger distribution network to expand reach and sales.

Margin guidance

Category 3

FY'24: Revenue expected to be flat compared to FY'23; margins to improve slightly but not significantly. The acquisition is expected to be EPS dilutive in FY'24.
FY'25 and onwards: Confident of achieving low double-digit to mid-teens revenue growth for the acquired business.
EBITDA margins expected to rise to mid-20% range from FY'25 onwards, driven by cost synergies and scale.
Long-term growth potential is mid-teens in revenue growth, reflecting category potential and company initiatives.
Despite 10% growth being a baseline business case, the management ambition is to exceed that with mid-teens growth.
Margin expansion and cost efficiencies (including SKU rationalization and distribution gains) will support operating profit improvements.
Tax structuring with brand depreciation in tax books will lower cash tax outflows for 7-8 years, positively impacting net earnings.

See what Godrej Consumer management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

Godrej Consumer Products Limited plans to evaluate short-term financing initially for the acquisition.
As of March-end, the company is net cash.
They expect to be net debt for about the next six months, assuming current conditions.
With expected cash flows in FY'24, the company plans to return to a net cash position by mid-FY'24.
No mention of new equity fundraising was made in the provided transcript.
The focus appears to be on managing funding through short-term debt initially, then using operating cash flows to deleverage.

Order book

The provided transcript from the Godrej Consumer Products Limited conference call held on April 28, 2023, does not mention any information regarding current or expected order book or pending orders. The discussion primarily focuses on: - The strategic rationale for acquiring RCCL. - Category development and growth potential in Deodorants and Sexual Wellness. - SKU rationalization and cost synergies post-acquisition. - Market size and growth outlook for Deodorants (approx. Rs. 5,000 crore) and condoms (approx. Rs. 1,200 crore). - Distribution, margin improvement, and marketing investments. - Urban-rural split and consumer insights. No direct details about order book status or pending orders were disclosed in the available transcript pages.

See what Godrej Consumer management said on order book — free account, 30 seconds.

Capex plans

Yes

The transcript provided in the pages does not explicitly mention any specific current or future capex, capital investments, or strategic investments by Godrej Consumer Products Limited (GCPL). However, some relevant points indicative of strategic intent are: - GCPL is focusing on simplifying and rationalizing SKUs, especially in the acquired businesses like RCCL, which could imply operational investments to improve efficiency. - The company is addressing underpenetrated categories in India with a view to organic and inorganic growth opportunities. - There is emphasis on leveraging cost synergies, improving direct distribution, and selecting strategic areas like Deodorants and Sexual Wellness for growth. - GCPL is evaluating short-term financing for funding acquisitions and expects to move from net debt to net cash within FY24. - Significant marketing investments and supply chain scale-ups (e.g., larger aerosol procurement) are planned for growth and margin expansion from FY25 onwards. No explicit standalone capex figures or project announcements are provided in the transcript on these pages.

Track Godrej Consumer — get its next earnings analysis in your feed

How does Godrej Consumer rank vs peers in Personal Products?

Pro feature

ThisGodrej Consumer

Rev 3Mar 3

See where Godrej Consumer sits in Personal ProductsSee which companies these are, and every other name in the sector.Open rankings

How does Godrej Consumer rank in Personal Products?

Compare Godrej Consumer against every Personal Products company (Q4 FY23) on revenue, margins and earnings-call signals.

View Personal Products leaderboard →

What Godrej Consumer's management said in earlier quarters

Earlier calls (4)

Others in Personal Products this season

Honasa Consumer (Q2 FY27)
Revenue from operations for Q2 FY27: INR 731 Cr, a 35.9% YoY growth from INR 538 Cr in Q2 FY26. Key investor presentation takeaways from Honasa Consumer Ltd's Q
Emami (Q2 FY27)
Q2FY27 Revenue from Operations:** ₹1,088 crore, up 36% year-on-year . Key investor presentation takeaways from Emami Ltd's Q2 FY27 investor presentation — and h
Dabur India (Q2 FY27)
Consolidated Revenue: INR 3,563.1 crores in Q2 FY27, up 11.6% YoY (Page 27) . Key investor presentation takeaways from Dabur India Ltd's Q2 FY27 investor presen
JHS Svendgaard Laboratories (Q2 FY27)
2,077.1 lakhs in the same quarter of 2025, which reflects an approximate year-on-year growth of 10.8%. Key results statement takeaways from JHS Svendgaard Labor

Compare:vs Dabur India vs Colgate-Palmoliv vs Cupid

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Godrej Consumer Q4 FY23 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Godrej Consumer rank in Personal Products?

Continue your research

What Godrej Consumer's management said in earlier quarters

Others in Personal Products this season